A Massachusetts company is developing an all-in-one device that can test for many known pathogens on-site, addressing the time and cost disadvantages of having to transport samples to an off-site location.

The LX2 automated genetic analyzer uses light to determine whether and what pathogens are present in a given sample, all in a self-contained tabletop unit. Expected to be released in 2019, the diagnostic tool could have applications in food packaging, healthcare, security, and more.

Click here to read more about high-consequence pathogens.